Medviso is a reputable medical technology brand that has been empowering healthcare professionals and researchers since its establishment in 2007. With a strong focus on cardiovascular image analysis and 3D modeling applications, Medviso specializes in creating innovative software solutions for medical imaging analysis and workflow optimization. Their range of products includes Segment CMR for quantitative analysis of cardiac magnetic resonance images, Segment CT for quantitative analysis of cardiac computer tomography images, and Segment 3DPrint, which enables a seamless transition from DICOM images to high-quality, ready-to-print 3D models.

Medviso's software solutions have received FDA 510(k) clearance and CE-mark, and they actively support the global research community with their freely available research software, Segment. By collaborating closely with leading institutions such as Lund University and Skåne University Hospital, Medviso ensures that their products are at the forefront of medical technology. Through ongoing improvement and compliance with regulatory requirements, Medviso is committed to providing efficient, adaptable, and validated solutions that make a meaningful difference in healthcare